AAAAAA

   
Results: 1-20 |
Results: 20
ANTITUMOR AND MYELOTOXIC ACTIVITY OF A NEW CLASS OF TAXANES (14-BETA-HYDROXY-10-DEACETYLBACCATIN-III DERIVATIVES)
Authors: DISTEFANO M FERLINI C PIERELLI L DEVINCENZO R RIVA A BOMBARDELLI E OJIMA I MANCUSO S SCAMBIA G
Citation: M. Distefano et al., ANTITUMOR AND MYELOTOXIC ACTIVITY OF A NEW CLASS OF TAXANES (14-BETA-HYDROXY-10-DEACETYLBACCATIN-III DERIVATIVES), Annals of oncology, 9, 1998, pp. 348-348
ANTITUMOR-ACTIVITY OF PACLITAXEL (TAXOL) ANALOGS ON MDR-POSITIVE HUMAN CANCER-CELLS
Authors: DISTEFANO M SCAMBIA G FERLINI C GALLO D DEVINCENZO R FILIPPINI P RIVA A BOMBARDELLI E MANCUSO S
Citation: M. Distefano et al., ANTITUMOR-ACTIVITY OF PACLITAXEL (TAXOL) ANALOGS ON MDR-POSITIVE HUMAN CANCER-CELLS, Anti-cancer drug design (Print), 13(5), 1998, pp. 489-499
ANTIPROLIFERATIVE ACTIVITY OF COLCHICINE ANALOGS ON MDR-POSITIVE AND MDR-NEGATIVE HUMAN CANCER CELL-LINES
Authors: DEVINCENZO R SCAMBIA G FERLINI C DISTEFANO M FILIPPINI P RIVA A BOMBARDELLI E POCAR D GELMI ML PANICI PB MANCUSO S
Citation: R. Devincenzo et al., ANTIPROLIFERATIVE ACTIVITY OF COLCHICINE ANALOGS ON MDR-POSITIVE AND MDR-NEGATIVE HUMAN CANCER CELL-LINES, Anti-cancer drug design, 13(1), 1998, pp. 19-33
ANTIPROLIFERATIVE ACTIVITY OF A NEW CLASS OF TAXANES (14-BETA-HYDROXY-10-DEACETYLBACCATIN-III DERIVATIVES) ON MULTIDRUG-RESISTANCE-POSITIVEHUMAN CANCER-CELLS (VOL 72, PG 844, 1997)
Authors: DISTEFANO M SCAMBIA G FERLINI C GAGGINI C DEVINCENZO R RIVA A BOMBARDELLI E OJIMA I FATTOROSSI A PANICI PB MANCUSO S
Citation: M. Distefano et al., ANTIPROLIFERATIVE ACTIVITY OF A NEW CLASS OF TAXANES (14-BETA-HYDROXY-10-DEACETYLBACCATIN-III DERIVATIVES) ON MULTIDRUG-RESISTANCE-POSITIVEHUMAN CANCER-CELLS (VOL 72, PG 844, 1997), International journal of cancer, 76(1), 1998, pp. 164-164
ANTIPROLIFERATIVE ACTIVITY OF A NEW CLASS OF TAXANES (14-BETA-HYDROXY-10-DEACETYLBACCATIN-III DERIVATIVES) ON MULTIDRUG-RESISTANCE-POSITIVEHUMAN CANCER-CELLS
Authors: DISTEFANO M SCAMBIA G FERLINI C GAGGINI C DEVINCENZO R RIVA A BOMBARDELLI E OJIMA I FATTOROSSI A PANICI PB MANCUSO S
Citation: M. Distefano et al., ANTIPROLIFERATIVE ACTIVITY OF A NEW CLASS OF TAXANES (14-BETA-HYDROXY-10-DEACETYLBACCATIN-III DERIVATIVES) ON MULTIDRUG-RESISTANCE-POSITIVEHUMAN CANCER-CELLS, International journal of cancer, 72(5), 1997, pp. 844-850
ANTIPROLIFERATIVE EFFECT OF SILYBIN ON GYNECOLOGICAL MALIGNANCIES - SYNERGISM WITH CISPLATIN AND DOXORUBICIN
Authors: SCAMBIA G DEVINCENZO R RANELLETTI FO PANICI PB FERRANDINA G DAGOSTINO G FATTOROSSI A BOMBARDELLI E MANCUSO S
Citation: G. Scambia et al., ANTIPROLIFERATIVE EFFECT OF SILYBIN ON GYNECOLOGICAL MALIGNANCIES - SYNERGISM WITH CISPLATIN AND DOXORUBICIN, European journal of cancer, 32A(5), 1996, pp. 877-882
TAMOXIFEN SYNERGIZES THE ANTIPROLIFERATIVE EFFECT OF CISPLATIN IN HUMAN OVARIAN-CANCER CELLS - ENHANCEMENT OF DNA PLATINATION AS A POSSIBLEMECHANISM
Authors: ERCOLI A SCAMBIA G DEVINCENZO R ALIMONTI A PETRUCCI F FATTOROSSI A ISOLA G PANICI PB CAROLI S MANCUSO S
Citation: A. Ercoli et al., TAMOXIFEN SYNERGIZES THE ANTIPROLIFERATIVE EFFECT OF CISPLATIN IN HUMAN OVARIAN-CANCER CELLS - ENHANCEMENT OF DNA PLATINATION AS A POSSIBLEMECHANISM, Cancer letters, 108(1), 1996, pp. 7-14
MODULATORY EFFECT OF TAMOXIFEN AND ICI-182,780 ON ADRIAMYCIN RESISTANCE IN MCF-7 HUMAN BREAST-CANCER CELLS
Authors: DEVINCENZO R SCAMBIA G PANICI PB FATTOROSSI A BONANNO G FERLINI C ISOLA G PERNISCO S MANCUSO S
Citation: R. Devincenzo et al., MODULATORY EFFECT OF TAMOXIFEN AND ICI-182,780 ON ADRIAMYCIN RESISTANCE IN MCF-7 HUMAN BREAST-CANCER CELLS, International journal of cancer, 68(3), 1996, pp. 340-348
QUERCETIN NOT ONLY INHIBITS P-GLYCOPROTEIN EFFLUX ACTIVITY BUT ALSO INHIBITS CYP3A ISOZYMES - REPLY
Authors: SCAMBIA G RANELLETTI FO BENEDETTIPANICI P DEVINCENZO R BONANNO G FERRANDINA G PIANTELLI M MANCUSO S
Citation: G. Scambia et al., QUERCETIN NOT ONLY INHIBITS P-GLYCOPROTEIN EFFLUX ACTIVITY BUT ALSO INHIBITS CYP3A ISOZYMES - REPLY, Cancer chemotherapy and pharmacology, 36(5), 1995, pp. 449-450
EFFECT OF SYNTHETIC AND NATURALLY-OCCURRING CHALCONES ON OVARIAN-CANCER CELL-GROWTH - STRUCTURE-ACTIVITY-RELATIONSHIPS
Authors: DEVINCENZO R SCAMBIA G PANICI PB RANELLETTI FO BONANNO G ERCOLI A DELLEMONACHE F FERRARI F PIANTELLI M MANCUSO S
Citation: R. Devincenzo et al., EFFECT OF SYNTHETIC AND NATURALLY-OCCURRING CHALCONES ON OVARIAN-CANCER CELL-GROWTH - STRUCTURE-ACTIVITY-RELATIONSHIPS, Anti-cancer drug design, 10(6), 1995, pp. 481-490
BISDIOXOPIPERAZINE, (-1,2-BIS(3,5-DIOXOPIPERAZINYL-1-YL)PROPANE (ICRF-187), ENHANCES THE ANTIPROLIFERATIVE EFFECT OF CISPLATIN ON HUMAN OVARIAN-CANCER CELLS())
Authors: SCAMBIA G BITTA RD PANICI PB DEVINCENZO R CONTU G ERCOLI A BONANNO G PIERELLI L MANCUSO S
Citation: G. Scambia et al., BISDIOXOPIPERAZINE, (-1,2-BIS(3,5-DIOXOPIPERAZINYL-1-YL)PROPANE (ICRF-187), ENHANCES THE ANTIPROLIFERATIVE EFFECT OF CISPLATIN ON HUMAN OVARIAN-CANCER CELLS()), Gynecologic oncology, 57(1), 1995, pp. 16-22
METHYL-P-HYDROXYPHENYLLACTATE-ESTERASE ACTIVITY AND TYPE-II ESTROGEN-BINDING SITES IN OVARIAN-CANCER - CORRELATION WITH BIOLOGICAL AND CLINICOPATHOLOGICAL PARAMETERS
Authors: RANELLETTI FO SCAMBIA G PANICI PB PIANTELLI M FERRANDINA G DAGOSTINO G DEVINCENZO R RINELLI A ISOLA G MANCUSO S
Citation: Fo. Ranelletti et al., METHYL-P-HYDROXYPHENYLLACTATE-ESTERASE ACTIVITY AND TYPE-II ESTROGEN-BINDING SITES IN OVARIAN-CANCER - CORRELATION WITH BIOLOGICAL AND CLINICOPATHOLOGICAL PARAMETERS, International journal of cancer, 62(5), 1995, pp. 536-541
MECHANISMS AND MODULATION OF RESISTANCE TO ANTHRACYCLINES
Authors: SCAMBIA G PANICI PB CONTU G DEVINCENZO R FERRANDINA G ISOLA G MACCIO A MANCUSO S
Citation: G. Scambia et al., MECHANISMS AND MODULATION OF RESISTANCE TO ANTHRACYCLINES, International journal of oncology, 4(4), 1994, pp. 951-959
CLINICAL-SIGNIFICANCE OF CATHEPSIN-D IN PRIMARY OVARIAN-CANCER
Authors: SCAMBIA G PANICI PB FERRANDINA G SALERNO G DAGOSTINO G DISTEFANO M DEVINCENZO R ERCOLI A MANCUSO S
Citation: G. Scambia et al., CLINICAL-SIGNIFICANCE OF CATHEPSIN-D IN PRIMARY OVARIAN-CANCER, European journal of cancer, 30A(7), 1994, pp. 935-940
QUERCETIN POTENTIATES THE EFFECT OF ADRIAMYCIN IN A MULTIDRUG-RESISTANT MCF-7 HUMAN BREAST-CANCER CELL-LINE - P-GLYCOPROTEIN AS A POSSIBLE TARGET
Authors: SCAMBIA G RANELLETTI FO PANICI PB DEVINCENZO R BONANNO G FERRANDINA G PIANTELLI M BUSSA S RUMI C CIANFRIGLIA M MANCUSO S
Citation: G. Scambia et al., QUERCETIN POTENTIATES THE EFFECT OF ADRIAMYCIN IN A MULTIDRUG-RESISTANT MCF-7 HUMAN BREAST-CANCER CELL-LINE - P-GLYCOPROTEIN AS A POSSIBLE TARGET, Cancer chemotherapy and pharmacology, 34(6), 1994, pp. 459-464
QUERCETIN ENHANCES TRANSFORMING GROWTH-FACTOR BETA(1) SECRETION BY HUMAN OVARIAN-CANCER CELLS
Authors: SCAMBIA G PANICI PB RANELLETTI FO FERRANDINA G DEVINCENZO R PIANTELLI M MASCIULLO V BONANNO G ISOLA G MANCUSO S
Citation: G. Scambia et al., QUERCETIN ENHANCES TRANSFORMING GROWTH-FACTOR BETA(1) SECRETION BY HUMAN OVARIAN-CANCER CELLS, International journal of cancer, 57(2), 1994, pp. 211-215
SIGNIFICANCE OF EPIDERMAL GROWTH-FACTOR RECEPTOR EXPRESSION IN PRIMARY HUMAN ENDOMETRIAL CANCER
Authors: SCAMBIA G PANICI PB FERRANDINA G BATTAGLIA F DISTEFANO M DANDREA G DEVINCENZO R MANESCHI F RANELLETTI FO MANCUSO S
Citation: G. Scambia et al., SIGNIFICANCE OF EPIDERMAL GROWTH-FACTOR RECEPTOR EXPRESSION IN PRIMARY HUMAN ENDOMETRIAL CANCER, International journal of cancer, 56(1), 1994, pp. 26-30
TYPE-II ESTROGEN-BINDING SITES IN HUMAN OVARIAN-CANCER - CORRELATION WITH ESTROGEN, PROGESTERONE, AND EPIDERMAL GROWTH-FACTOR RECEPTOR
Authors: FERRANDINA G SCAMBIA G PANICI PB RANELLETTI FO DEVINCENZO R PIANTELLI M DISTEFANO M CAPELLI A MANCUSO S
Citation: G. Ferrandina et al., TYPE-II ESTROGEN-BINDING SITES IN HUMAN OVARIAN-CANCER - CORRELATION WITH ESTROGEN, PROGESTERONE, AND EPIDERMAL GROWTH-FACTOR RECEPTOR, Gynecologic oncology, 49(1), 1993, pp. 67-72
QUERCETIN INDUCES TYPE-II ESTROGEN-BINDING SITES IN ESTROGEN-RECEPTOR-NEGATIVE (MDA-MB231) AND ESTROGEN-RECEPTOR-POSITIVE (MCF-7) HUMAN BREAST-CANCER CELL-LINES
Authors: SCAMBIA G RANELLETTI FO PANICI PB PIANTELLI M DEVINCENZO R FERRANDINA G BONANNO G CAPELLI A MANCUSO S
Citation: G. Scambia et al., QUERCETIN INDUCES TYPE-II ESTROGEN-BINDING SITES IN ESTROGEN-RECEPTOR-NEGATIVE (MDA-MB231) AND ESTROGEN-RECEPTOR-POSITIVE (MCF-7) HUMAN BREAST-CANCER CELL-LINES, International journal of cancer, 54(3), 1993, pp. 462-466
SIGNIFICANCE OF EPIDERMAL GROWTH-FACTOR RECEPTOR IN ADVANCED OVARIAN-CANCER
Authors: SCAMBIA G PANICI PB BATTAGLIA F FERRANDINA G BAIOCCHI G GREGGI S DEVINCENZO R MANCUSO S
Citation: G. Scambia et al., SIGNIFICANCE OF EPIDERMAL GROWTH-FACTOR RECEPTOR IN ADVANCED OVARIAN-CANCER, Journal of clinical oncology, 10(4), 1992, pp. 529-535
Risultati: 1-20 |